As the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines enter the clinic, it is now business critical that allogeneic drug developers prove the potential of the off-the-shelf approach to enable reduced cost of goods and greater access for patients.

As the must-attend meeting for the allogeneic community, the 7th Annual Allogeneic Cell Therapies Summit will address the critical challenges in optimizing complex gene engineering, ensuring safety and potency of off-the-shelf cell therapies to accelerate your path to clinical and commercial success.

Spanning preclinical development through to manufacturing and process development, brainstorm with industry pioneers the best approaches for developing preclinical assays, targeting novel cell types and streamlining automated manufacturing processes to support scale-up for larger patient populations.

Covering disease indications in both oncology and autoimmunity, connect with expert speakers from Adicet Bio, Caribou Bioscience, IN8Bio and more, as they share innovations in non-viral engineering and manufacturing, the latest advancements in cell expansion techniques and benchmark new donor retention strategies for a smoother journey to the clinic and beyond!